Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
John M Leonard
2 Nov 2026
President and CEO
Sold on a plan
9,000
$11.99
$107.91K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 199,822
History held since 9 May 2016